Altre lingue Filament Health Corp.

Azioni

FLHLF

CA31685W1068

Mercato chiuso - OTC Markets Altri mercati azionari 20:05:52 10/07/2024			Variaz. 5gg	Var. 1 gen.
0,034 ^USD	-0,29%		+1,49%	-37,15%

03/06	Filament Health annuncia l'autorizzazione alla sperimentazione clinica di Fase 2 per PEX010 nel trattamento del disturbo da uso di metamfetamina	CI
14/05	Filament Health Corp. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Negev Capital Fund One, L.P. Reports Updated Holdings in Filament Health Corp.	15/06
FILAMENT HEALTH ANNOUNCES CLOSING OF WARRANT EXERCISE, NOTE CONVERSION AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES	12/06
Filament Health Corp. announced that it has received CAD 1 million in funding from Negev Capital	12/06
FILAMENT HEALTH ANNOUNCES AUTHORIZATION OF PHASE 2 CLINICAL TRIAL FOR PEX010 IN THE TREATMENT OF METHAMPHETAMINE USE DISORDER	03/06
Filament Health Announces Authorization of Phase 2 Clinical Trial for PEX010 in the Treatment of Methamphetamine Use Disorder	03/06
FILAMENT HEALTH ANNOUNCES WARRANT EXERCISE AND NOTE CONVERSION BY NEGEV CAPITAL AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES TO BENJAMIN LIGHTBURN, CHIEF EXECUTIVE OFFICER	03/06
Filament Health Corp. announced that it expects to receive CAD 1 million in funding from Negev Capital and another investor	03/06
FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS	14/05
Filament Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS	04/05
Filament Health Corp. Announces Change to Board of Directors	04/05
FILAMENT HEALTH TO DISCUSS ITS DRUG DEVELOPMENT PLATFORM IN FIRESIDE CHAT WITH WATER TOWER RESEARCH ON APRIL 4, 2024 AT 12PM ET	03/04
FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS	03/04
Filament Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	03/04
FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS	28/03
Filament Health Corp. Announces Appointment of Michael Messinger to Its Board of Directors and Chair of the Audit Committee	28/03
Filament Health Corp. Announces Chief Financial Officer Changes	28/03
FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION	19/03
Filament Health Corp. Announces Shipments of Botanical Psilocybin to Four Countries for Clinical Investigation	19/03
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL	15/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Filament Health Corp.

Azioni

FLHLF

CA31685W1068

Altre lingue

Filtri